Alnylam Pharmaceuticals
ALNY
#534
Rank
NZ$74.93 B
Marketcap
NZ$567.21
Share price
0.82%
Change (1 day)
15.07%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company